Author

Qingyi Yang

Pfizer (United States)ORCID 0000-0001-5269-0494Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alexey V. GribenkoiD· 1 shared Annaliesa S. AndersoniD· 1 shared Bradley Scott PerriniD· 1 shared Hao LiiD· 1 shared Jonathan T. LeeiD· 1 shared Paul LiberatoriD· 1 shared Rhonda D. CardiniD· 1 shared Yuao ZhuiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alexey V. GribenkoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsbioRxivPreprintMar 29, 2022

Genetic surveillance of SARS-CoV-2 Mpro reveals high sequence and structural conservation prior to the introduction of protease inhibitor Paxlovid

Jonathan T. Lee, Qingyi Yang, Alexey V. Gribenko…·Hao Li

This study analyzes SARS-CoV-2 Mpro sequences from 4.89 million genomes to assess mutation patterns and structural conservation before Paxlovid use, finding rare escape mutations and strong purifying selection.

6 citations

humanwhole-genome sequencing

𝕏 PostBluesky